Access to Medicines Ireland 3rd Annual Conference

After the big successes of our two previous conferences, we are back again with a range of new expertise from Ireland and abroad. Registration is mandatory, so please find a link to the Eventbrite page and register here.

This conference will explore proposals to reform the current medicines innovation model in order to develops drugs with public health and accessibility as the priority.

Conference Speakers

Professor Michael Barry, Clinical Director of the National Centre for Pharmacoeconomics

Mr James Love, Director, Knowledge Ecology International

Ms Els Torreele, Executive Director, Médicins Sans Frontières, Global Access Campaign

Mr Diarmaid McDonald, Just Treatment UK

Mr Bas Leerink, Chairperson of Committee which prepared the report of the Dutch Health Council, Development of New Medicines: Better, Faster Cheaper

Ms Kay English Curtin, Patient Expert

Professor Mariana Mazzucato, Video Link- Institute of Innovation and Public Purpose, University College London

Representative of Irish Pharmaceutical Industry- To Be Confirmed

Policy Document Launch in Dáil Éireann

We are delighted with the reception we got in parliament today for the launch of our policy document, Access to Medicines: A High Price to Pay. A big thank you to Michael Harty TD, Chairman of Oireachtas Health Committee for hosting us and for the engagement of many TDs on the health committee and those with an interest in fighting for health equity. We look forward to working with each other in the future to address the issue of high drug prices in Ireland and abroad.

European Access to Medicines Manifesto

The looming European elections provide an important opportunity for EU citizens to ensure that the EU is serious about the health and well being of its citizens. This manifesto outlines key asks that will help put citizens at the centre of policy-making in this area and ensure that Access to Medicines is prioritised on the agenda of the next European Parliament and the new European Commission:

Find the EU Manifesto HERE

Access to Medicines responds to IPHA’s concerns that Irish patients aren’t getting access to medicines quickly enough. We agree!

The Irish Pharmaceutical Healthcare Association (IPHA) wrote an article about how “Irish patients are not getting access to medicines quickly enough”.

We agree, they aren’t. But this is due to monopolies, high drug prices and failing to meet cost effectiveness criteria. Read our response here: …

IPHA original article:

The Irish Times view on drug prices: Big Pharma’s hostages

An editorial from The Irish Times on high drug prices. An important step in recognising the issues we face due to the current intellectual property incentivisation model. 

"Rising prices of new medicines are having a profound impact globally and are now exceeding the capacity of even the wealthiest of countries to pay, a recent Dublin conference on drug prices heard."

Ellen t' Hoen, a leading IP expert at our Access to Medicines Conference told the Irish Times that Pharma frequently holds governments in a "hostage situation" by using fear tactics to discourage opposition to high drug prices. 

We welcome the Editor's position on opening dialogue for the exploration of alternative drug pricing models.

"Yet the presence of so many drug manufacturers in Ireland means we are in a unique position to open a dialogue with industry to explore alternative models for the pricing of medicines."

Full article here:

Fear and secrecy used to drive medicine costs – conference told

The Irish Times came to our Access to Medicines Conference to ask our expert panelists about high drug prices. Ellen t' Hoen, a Dutch expert in intellectual property law and Yannis Natsis, policy manager of the European Health Alliance both call for greater "transparency across the sector" and a "need to change the way we incentivise medical R&D.”

Find the full link here:

Price pressure and new medicines

Access to Medicines Ireland has written a Letter to the Editor about their previous article entitled, 'Price pressure keeps nine new drugs from Irish patients'. Dr. Kieran Harkin lays out what the Irish government can do to greatly reduce the cost of these drugs and make them available to the patients who need them. 

Read our Letter to the Editor (30/04/2018) here:

Read the original article in the Irish Times, written by Dominic Coyle (23/04/2018) here:

Join us at our second annual Access to Medicines Ireland conference

Rising prices of new medicines are having a profound impact globally and are now exceeding the capacity of even the wealthiest of countries to pay. A panel of leading international experts, patient advocates and industry will come together in Dublin on the 2nd of May to discuss the current model of drugs development and propose interventions and alternative models with the potential to dramatically lower the prices of new medicines.

There will be 2 panels followed by Q&A and refreshments. This conference hopes to engage and inform all stakeholders - government, policy-makers, health care professionals, industry, NGOs, civil society groups and members of the public alike.

Please register on our Eventbrite page. Few places left!

Find photos of our event here: